Non-small cell lung cancer targeted therapy, third generation EGFR-TKI, treats EGFRm NSCLC with Ex19Del or L858R mutations, antimesencephalic metastasis activity, irreversible inhibitor,
Sale!
Lucius
Replica Osimertinib EGFRm NSCLC Therapy
Original price was: $607.00.$448.00Current price is: $448.00.
Non-small cell lung cancer targeted therapy, third generation EGFR-TKI, treats EGFRm NSCLC with Ex19Del or L858R mutations, antimesencephalic metastasis activity, irreversible inhibitor,